Asec 2022 2022
DOI: 10.3390/asec2022-13766
|View full text |Cite
|
Sign up to set email alerts
|

Brain Targeting of Antidepressant and Anxiolytic Drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Nanoparticles are drug delivery systems with a particle size of 10-100 nm that are generated using polymer materials as carriers to adsorb or encapsulate drugs within the carrier material (Antunes et al, 2023). Nanoparticles can protect encapsulated drugs from degradation, preventing their unintended removal from the nasal cavity, extending the residence time of drugs in the nasal mucosa, and promoting the direct transport of certain drugs from the nasal cavity to the brain, without increasing drug concentrations within the general circulation; thus, nanoparticles can help facilitate braintargeted drug delivery (Ferreira et al, 2023).…”
Section: Nanoparticlesmentioning
confidence: 99%
“…Nanoparticles are drug delivery systems with a particle size of 10-100 nm that are generated using polymer materials as carriers to adsorb or encapsulate drugs within the carrier material (Antunes et al, 2023). Nanoparticles can protect encapsulated drugs from degradation, preventing their unintended removal from the nasal cavity, extending the residence time of drugs in the nasal mucosa, and promoting the direct transport of certain drugs from the nasal cavity to the brain, without increasing drug concentrations within the general circulation; thus, nanoparticles can help facilitate braintargeted drug delivery (Ferreira et al, 2023).…”
Section: Nanoparticlesmentioning
confidence: 99%